Home

How the New Medicare Prescription Drug Bill Affects Public Retirees
Madeline Smith,
House Ways and Means Subcommittee on Health
Kate Leone,
Office of Sen. Tom Daschle (D-SD)

Two Capitol Hill experts in Medicare legislation offered starkly contrasting views of P.L. 108-173, the Medicare prescription drug law Congress approved last December. The law offers the largest expansion of Medicare benefits since its creation in 1965, but has been criticized by Democrats and Republicans because of coverage gaps and delays in coverage.

The standard benefit, which becomes effective in 2006, offers a prescription drug benefit for a $35 monthly premium. There is a $250 annual deductible, with 75% coverage up to $2,250. The law offers no coverage between $2,250 and $5,000 and requires an individual to pay $3,600 out of pocket before the benefits begins to pay 95% of drug costs. 

Smith, a staffer who works for House Ways and Means Chairman Bill Thomas (R-CA), said that the law offers numerous improvements. She emphasized that whatever limitations it has, the law represents the first prescription drug coverage many Medicare beneficiaries have ever had. The coverage will be particularly valued, she believes, by anyone who loses their private sector employer health insurance coverage.

In contrast, Kate Leone, aide to Senate Majority Leader Tom Daschle (D-SD), said the law will actually result in lower benefits for many retirees and will eliminate many of the options in coverage retirees now enjoy. She expressed concern not only on several of the law’s provisions but how it was debated and passed.

Leone suggested that many in Congress are also concerned about the law because some of its long-term costs are just now becoming known. Last November Daschle introduced two bills to revise the prescription drug bill S 1974 and S 1999. Provisions would address issues such as the re-importation of prescription drugs and allow the federal government to negotiate the prices of drug to get a discount for Medicare-covered retirees. 

Smith is a professional staff member of the House Ways and Means Committee’s majority staff. She works with the Health Subcommittee, which has jurisdiction over Medicare. Leone is a key legislative aide for Sen. Tom Daschle. She focuses primarily on the issues of health care and Medicare.

Welcoming Remarks
Elmer J. Khal
NCPERS President

The US Economy in 2004
Kristin J. Forbes, Member
The White House Council of Economic Advisers

Political Overview of the 108th Congress and Elections
Jack Germond
Keynote Speaker

Outlook on Administration’s Pension Activities for 2004: Will Public Pensions be Affected?
William Sweetnam
Benefits Tax Counsel, Department of the Treasury

Social Security: What's Ahead in this Congress?
Kim Hildred
Staff Director, Ways and Means Subcommittee on Social Security

Tom Klouda
Social Security General Assistant, Senate Finance Committee

How Will the New Medicare Prescription Drug Bill Affect Public Retirees?
Madeline Smith
Professional Staff, House Ways and Means Subcommittee on Health

Kate Leone
Legislative Assistant, Office of Sen. Tom Daschle (SD)

Legislative Overview of the 108th Congress
Frederick H. Nesbitt
NCPERS Executive Director and Legislative Counsel

Health Care Issues for Public Employees and Retirees
Mark Goldberg
Senior Vice President for Policy and Strategy
National Coalition on Health Care

Paul Zorn
Gabriel, Roeder, Smith and Company

Hank H. Kim, JD
NCPERS Director of Governmental Relations and Counsel

Outlook on Pension Legislation This Year
Scott DeFife
Senior Policy Analyst, Office of Minority Leader Steny Hoyer (MD)

Investment Issues Affecting the Security of Plan Assets
Ann Yerger
Deputy Director, Council on Institutional Investors